Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies
E. Odore, F. Lokiec, E. Cvitkovic, M. Bekradda, P. Herait, F. Bourdel, C. Kahatt, E. Raffoux, A. Stathis, C. Thieblemont, B. Quesnel, D. Cunningham, M. E. Riveiro, K. RezaïVolume:
55
Language:
english
Journal:
Clinical Pharmacokinetics
DOI:
10.1007/s40262-015-0327-6
Date:
March, 2016
File:
PDF, 1.14 MB
english, 2016